All Stories

  1. Extracellular Vesicles as Bridges Between Host Immune Cells and Graft Organ During Cellular Rejection
  2. A dynamic clamping approach using in silico IK1 current for discrimination of chamber-specific hiPSC-derived cardiomyocytes
  3. Plasma Extracellular Vesicles as Liquid Biopsy to Unravel the Molecular Mechanisms of Cardiac Reverse Remodeling Following Resynchronization Therapy?
  4. Fndc5/irisin-enriched extracellular vesicles: a new hormonal relay in the regular race against vascular ageing
  5. Identification of a serum and urine extracellular vesicle signature predicting renal outcome after kidney transplant
  6. Myosins and MyomiR Network in Patients with Obstructive Hypertrophic Cardiomyopathy
  7. Risk stratification of patients with SARS-CoV-2 by tissue factor expression in circulating extracellular vesicles
  8. Investigating the Paracrine Role of Perinatal Derivatives: Human Amniotic Fluid Stem Cell-Extracellular Vesicles Show Promising Transient Potential for Cardiomyocyte Renewal
  9. Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles
  10. Supervised and unsupervised learning to define the cardiovascular risk of patients according to an extracellular vesicle molecular signature
  11. Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles
  12. Stress-induced premature senescence is associated with a prolonged QT interval and recapitulates features of cardiac aging
  13. Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection
  14. Structural and Electrophysiological Changes in a Model of Cardiotoxicity Induced by Anthracycline Combined With Trastuzumab
  15. Profiling Inflammatory Extracellular Vesicles in Plasma and Cerebrospinal Fluid: An Optimized Diagnostic Model for Parkinson’s Disease
  16. Cardiac Graft Assessment in the Era of Machine Perfusion: Current and Future Biomarkers
  17. A Changing Paradigm in Heart Transplantation: An Integrative Approach for Invasive and Non-Invasive Allograft Rejection Monitoring
  18. An exosomal-carried short periostin isoform induces cardiomyocyte proliferation
  19. Insights into therapeutic products, preclinical research models and clinical trials in cardiac regenerative and reparative medicine: where are we now and the way ahead. Current opinion paper of the ESC working group on cardiovascular regenerative and r...
  20. Circulating extracellular vesicles as non-invasive biomarker of rejection in heart transplant
  21. Sphingolipid composition of circulating extracellular vesicles after myocardial ischemia
  22. Immune profiling of plasma-derived extracellular vesicles identifies Parkinson disease
  23. An extracellular vesicle epitope profile is associated with acute myocardial infarction
  24. The swan song of dying cells
  25. Perioperative cardioprotection: back to bedside
  26. Message in a Bottle: Upgrading Cardiac Repair into Rejuvenation
  27. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes
  28. Ticagrelor Enhances Release of Anti-Hypoxic Cardiac Progenitor Cell-Derived Exosomes Through Increasing Cell Proliferation In Vitro
  29. Human Induced Pluripotent Stem Cells Derived from a Cardiac Somatic Source: Insights for an In-Vitro Cardiomyocyte Platform
  30. Inflammatory extracellular vesicles prompt heart dysfunction via TRL4-dependent NF-κB activation
  31. EXODEVICE: Continuous Perfusion Large Scale Exosome Cultivation Bioreactor
  32. Reactivating endogenous mechanisms of cardiac regeneration via paracrine boosting using the human amniotic fluid stem cell secretome
  33. Flow Cytometric Analysis of Extracellular Vesicles from Cell-conditioned Media
  34. Flow Cytometric Analysis of Extracellular Vesicles from Cell-conditioned Media
  35. Exosomal Expression of CXCR4 Targets Cardioprotective Vesicles to Myocardial Infarction and Improves Outcome after Systemic Administration
  36. Circulating blood cells and extracellular vesicles in acute cardioprotection
  37. Exosomes From Human Cardiac Progenitor Cells for Therapeutic Applications: Development of a GMP-Grade Manufacturing Method
  38. Notch pathway activation enhances cardiosphere in vitro expansion
  39. ALDH1A3 Is the Key Isoform That Contributes to Aldehyde Dehydrogenase Activity and Affects in Vitro Proliferation in Cardiac Atrial Appendage Progenitor Cells
  40. The Bioactivities of Exosomes secreted by Cardiac Progenitor Cells
  41. Beneficial effects of exosomes secreted by cardiac-derived progenitor cells and other cell types in myocardial ischemia
  42. Angiogenic activity of exosomes isolated from human pericardial fluid
  43. Exosomes: Therapy delivery tools and biomarkers of diseases
  44. Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity
  45. First Characterization of Human Amniotic Fluid Stem Cell Extracellular Vesicles as a Powerful Paracrine Tool Endowed with Regenerative Potential
  46. Roles of exosomes in cardioprotection
  47. Induced Pluripotent Stem (IPS) Cells to Assess the Cardioprotective and Proangiogenic Activities of Exosomes Secreted by Human Cardiac Progenitor Cells
  48. OUP accepted manuscript
  49. Epigenetic Regulation of Myocardial Homeostasis, Self-Regeneration and Senescence
  50. Combination of mi RNA 499 and mi RNA 133 Exerts a Synergic Effect on Cardiac Differentiation
  51. Exosomes for Intramyocardial Intercellular Communication
  52. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension
  53. Exosomes act as intercellular carriers of proteins and miRNAs
  54. Altered functional differentiation of mesoangioblasts in a genetic myopathy
  55. Human Cardiospheres as a Source of Multipotent Stem and Progenitor Cells
  56. Prometheus’s heart: what lies beneath
  57. Prevention of Myocardial Remodeling by Chronic INaL Blockade in Pulmonary Hypertension
  58. Exosomes and Cardiomyocytes
  59. Isolation and Expansion of Adult Cardiac Stem/Progenitor Cells in the Form of Cardiospheres from Human Cardiac Biopsies and Murine Hearts
  60. Aberrant Functional Differentiation of Cardiac Precursors from a Dystrophic Mouse
  61. Induced pluripotent stem cells: progress towards a biomedical application
  62. A Brugada syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization
  63. Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5-T cardiac MRI in a rat model of myocardial infarction
  64. Cardiac Cell Therapy: The Next (Re)Generation
  65. Evidence for the Existence of Resident Cardiac Stem Cells
  66. Bone marrow‐derived cells can acquire cardiac stem cells properties in damaged heart
  67. Caffeine-induced Ca2+ signaling as an index of cardiac progenitor cells differentiation
  68. Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application
  69. c-kit cardiac progenitor cells: What is their potential?
  70. New Perspectives to Repair a Broken Heart
  71. Differentiation of human adult cardiac stem cells exposed to extremely low-frequency electromagnetic fields
  72. Stem cells in the heart: What's the buzz all about? Part 2: Arrhythmic risks and clinical studies
  73. Stem cells in the heart: What's the buzz all about?—Part 1: Preclinical considerations
  74. Ion Cyclotron Resonance as a Tool in Regenerative Medicine
  75. Endogenous Cardiac Stem Cells
  76. Extremely low frequency magnetic field induces differentiation of the human cardiac stem cells
  77. Cardiac stem cells can be generated in damaged heart from bone marrow-derived cells
  78. The levels of GFP gene expression driven by regulatory regions of the mouse kit gene discriminate between HSC and progenitors
  79. Regenerative Potential of Cardiosphere-Derived Cells Expanded From Percutaneous Endomyocardial Biopsy Specimens
  80. Cardiac stem cells: isolation, expansion and experimental use for myocardial regeneration
  81. Cyclic Nucleotides and Neuroblastoma Differentiation
  82. Potential Role of Mycophenolate Mofetil in the Management of Neuroblastoma Patients
  83. Low levels of mycophenolic acid induce differentiation of human neuroblastoma cell lines